Volume 7, Issue 3, September 2019, Page: 66-80
The Utility of Diffusion Weighted Imaging and Dynamic Contrast Enhanced MRI Techniques in Differentiation Between Benign and Malignant Uterine Masses
Al-Shimaa Magdy Ammar, Radiology Department, Tanta University, Tanta, Egypt
Mohammed Mahmoud Dawoud, Radiology Department, Tanta University, Tanta, Egypt
Mohamed Mohamed Hefeda, Radiology Department, Tanta University, Tanta, Egypt
Manal Ezzat Badawy, Radiology Department, Tanta University, Tanta, Egypt
Essmat Hamdy Abozaid, Department of Obstetric and Gynecology, Faculty of Medicine, Tanta University, Tanta, Egypt
Received: Jul. 12, 2019;       Accepted: Aug. 15, 2019;       Published: Sep. 30, 2019
DOI: 10.11648/j.ijmi.20190703.12      View  560      Downloads  103
The aim of the present study was to evaluate the role of diffusion weighted imaging (DWI) and dynamic contrast enhanced magnetic resonance imaging (DCE-MRI) in the differentiation between benign and malignant endometrial, uterine and cervical masses. The study included 78 patients. All patients had uterine or cervical masses on ultrasound examination. All patients had conventional MRI, DWI, and DCE-MRI. The patients were classified into three groups: patients with endometrial masses, myometrial lesions and cervical masses. The mean ADC value of benign endometrial and myometrial lesions was higher significantly from malignant lesions (P value <0.001 and <0.001). The cut off value of ≤1.1×10-3mm2/sec as a predictor of malignant lesions yielded a sensitivity, specificity, PPV, NPV and accuracy of 89.65%, 91.54%, 88.67%, 92.41% and 95.21% respectively. The semi-quanitative parameters of DCE-MRI including the enhancement amplitude (EA), maximum slope (MS) and time of half rising (THR), all showed significant difference between the benign and malignant lesion in endometrial, myometrial and cervical lesions. In clinically and sonographically indeterminate endometrial, myometrial or cervical masses, DWI and DCE-MRI proved to be more accurate than conventional MRI in differentiation between benign and malignant masses, with the DWI and ADC value had more sensitivity and specificity especially in endometrial masses and should be included in the routine pelvic MRI. DCE-MRI should be reserved for still questionable cases after DWI and to study the vascularity of the lesions.
Uterine Masses, Endometrial Masses, DWI, Dynamic Contrast MRI, Functional MRI
To cite this article
Al-Shimaa Magdy Ammar, Mohammed Mahmoud Dawoud, Mohamed Mohamed Hefeda, Manal Ezzat Badawy, Essmat Hamdy Abozaid, The Utility of Diffusion Weighted Imaging and Dynamic Contrast Enhanced MRI Techniques in Differentiation Between Benign and Malignant Uterine Masses, International Journal of Medical Imaging. Vol. 7, No. 3, 2019, pp. 66-80. doi: 10.11648/j.ijmi.20190703.12
Copyright © 2019 Authors retain the copyright of this article.
This article is an open access article distributed under the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Jemal A, Bray F, Center MM, Ferlay J, Ward E, and Forman D, “Global cancer statistics,” CA: A Cancer Journal for Clinicians, vol. 61, no. 2, pp. 69-90, 2011.
Forman D, Bray F, Brewster D et al., Cancer Incidence in Five Continents, Vol. X. Cancer Incidence in Five Continents, IARC, Lyon, France, 2013.
Freedman LS, Edwards B, Ries L, and Young J, Cancer Incidence in Four Member Countries (Cyprus, Egypt, Israel, and Jordan) of the Middle East Cancer Consortium (MECC) Compared with US SEER. Cancer Incidence in Four Member Countries (Cyprus, Egypt, Israel, and Jordan) of the Middle East Cancer Consortium (MECC) Compared with US SEER, 2006.
Alshahrani S, Soliman AS, Hablas A, et al. Changes in Uterine Cancer Incidence Rates in Egypt. Obstetrics and Gynecology International. Volume 2018, Article ID 3632067, 10 pages.
Bonneau C. Value of ultrasonography and magnetic resonance imaging for the characterization of uterine mesenchymal tumors. Acta Obstetricia et GynecologicaScandinavica. 2014; 93 (3): 261-268.
Dueholm M, Lundorf E, Hansen ES, et al. Accuracy of magnetic resonance imaging and transvaginal ultrasonography in the diagnosis, mapping, and measurement ofuterine myomas. Am J Obstet Gynecol. 2002; 186 (3): 409-15. PMid: 11904599 http://dx.doi.org/10.1067/mob.2002.121725
Amant F, Coosemans A, Debiec-Rychter M, et al. Clinical management of uterine sarcomas. Lancet Oncol. 2009; 10: 1188. http://dx.doi.org/10.1016/S1470-2045 (09) 70226-8.
Sahdev A, Sohaib SA, Jacobs I et al (2001) MR imaging of uterine sarcomas. AJR Am J Roentgenol 177: 1307-1311.
Ueda H, Togashi K, Konishi I et al (1999) Unusual appearances ofuterine leiomyomas: MR imaging findings and their histopathologic backgrounds. Radiographics 19 Spec No: S131-S145.
Qayyum A. Diffusion-weighted imaging in the abdomen and pelvis: concepts and applications. Radiogr Rev Publ Radiol Soc N Am Inc. 2009; 29: 1797-810.
Nakamura K, Kajitani S, Joja I, Haruma T, Fukushima C, Kusumoto T, et al. The post treatment mean apparent diffusion coefficient of primary tumour is superior to pretreatment ADC mean of primary tumour as a predictor of prognosis with cervical cancer. Cancer Med. 2013; 2: 519-25.
Lyng H, Haraldseth O, Rofstad EK (2000) Measurement of cell density and necrotic fraction in human melanoma xenografts by diffusion weighted magnetic resonance imaging. Magn Reson Med 43: 828-836.
Sumi M, Ichikawa Y, Nakamura T (2007) Diagnostic ability of apparent diffusion coefficients for lymphomas and carcinomas in the pharynx. Eur Radiol 17: 2631-263.
Matoba M, Tonami H, Kondou T, Yokota H, Higashi K, Toga H, Sakuma T (2007) Lung carcinoma: diffusionweighted mr imaging-preliminary evaluation with apparent diffusion coefficient. Radiology 243: 570-577.
Matsuki M, Inada Y, Nakai G, Tatsugami F, Tanikake M, Narabayashi I, Masuda D, Arisaka Y, Takaori K, Tanigawa N (2007) Diffusion-weighed MR imaging of pancreatic carcinoma. Abdom Imaging 32 (4): 481-48.
Jacobs MA, Herskovits EH, Kim HS (2005) Uterine fibroids: diffusion weighted MR imaging for monitoring therapy with focused ultrasound surgery-preliminary study. Radiology 236: 196-203.
Matsuki M, Inada Y, Tatsugami F, Tanikake M, Narabayashi I, Katsuoka Y (2007) Diffusion-weighted MR imaging for urinary bladder carcinoma: initial results. Eur Radiol 17: 201-204.
Tasu K, Kuroki Y, Nawano S, Kuroki S, Tsukamoto T, Yamamoto S, Motoori K, Ueda T (2006) Hepatic metastases: diffusion-weighted sensitivity-encoding versus SPIO-enhanced MR imaging. Radiology 239: 122-130.
Naganawa S, Sato C, Kumada H, Ishigaki T, Miura S, Takizawa O (2005) Apparent diffusion coefficient in cervical cancer of the uterus: comparison with the normal uterine cervix. Eur Radiol 15: 71-78.
Tamai K, Koyama T, Saga T, Umeoka S, Mikami Y, Fujii S, Togashi K (2007) Diffusion-weighted MR imaging of uterine endometrial cancer. J Magn Reson Imaging 26: 682-687.
Liapi E, Kamel IR, Bluemke DA, Jacobs MA, Kim HS (2005) ssessment of response of uterine fibroids and myometrium to embolization using diffusion-weighted echoplanar MR imaging. J Comput Assist Tomogr 29: 83-86.
Shimada K, Ohashi I, Kasahara I, Watanabe H, Ohta S, Miyasaka N, Itoh E, Shibuya H (2004) Differentiation between completely hyalinized uterine leiomyomas and ordinary leiomyomas: three-phase dynamic magnetic resonance imaging (MRI) vs diffusion weighted MRI with very small b-factors. J Magn Reson Imaging 20: 97-104.
Gaustad JV, Brurberg KG, Simonsen TG, Mollatt CS, Rofstad EK. Tumor vascularity assessed by magnetic resonance imaging and intravital microscopy imaging. Neoplasia. 2008; 10 (4): 354-62. doi: 10.1593/neo. 08162.
Kim YE, Lim JS, Choi J, Kim D, Myoung S, Kim MJ, et al. Perfusion parameters of dynamic contrast-enhanced magnetic resonance imaging in patients with rectal cancer: correlation with microvascular density and vascular endothelial growth factor expression. Korean J Radiol. 2013; 14 (6): 878-85. doi: 10.3348/kjr.2013.14.6.878.[PubMed: 24265562].
Tofts PS, Brix G, Buckley DL, Evelhoch JL, Henderson E, Knopp MV. Estimating kinetic parameters from dynamic contrast-enhanced T 1-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging. 1999; 10 (3): 223-32.
Choyke PL, Dwyer AJ, Knopp MV. Functional tumor imaging with dynamic contrast-enhanced magnetic resonance imaging. J Magn Reson Imaging. 2003; 17: 509-520. [PubMed: 12720260] 3. NCI. CIP guidelines.
Kierans AS, G. L. Bennett, M. HaghighiUtility of conventional and diffusion-weighted MRI features in distinguishing benign from malignant endometrial lesions Eur J Radiol, 83 (4) (2013), pp. 726-732.
Fujii S, E. Matsusue, J. Kigawa, et al. Diagnostic accuracy of the apparent diffusion coefficient in differentiating benign from malignant uterine endometrial cavity lesions initial results Eur Radiol, 18 (2) (2008), pp. 384-389.
Elsammak A, Shehata SM, Abulezz M, Gouhar G: Efficiency of diffusion weighted magnetic resonance in differentiation between benign and malignant endometrial lesions. The Egyptian Journal of Radiology and Nuclear Medicine 48 (2017) 751-759.
Beddy P, Moyle P, Kataoka M, Yamamoto AK, Joubert I, Lomas D, Crawford R, Sala E. evaluation of depth of myometrial invasion and overall staging in endometrial cancer: comparison of diffusion-weighted and dynamic contrast-enhanced MR imaging. Radiology. 2012 Feb; 262 (2): 530-7. doi: 10.1148/radiol.11110984. Epub 2011 Nov 23.
Szafer A, Zhong J, Gore JC (1995) Theoretical model for water diffusion in tissues. Magn Reson Med 33: 697-712.
Liu KF, Li F, Tatlisumak T, Garcia JH, Sotak CH, Fisher M, Fenstermacher JD (2001) Regional variations in the apparent diffusion coefficient and the intracellular distribution of water in rat brain during acute focal ischemia. Stroke 32: 1897-1905.
Knight RA, Ordidge R, Helpern J, Chopp M, Rodolosi L, Peck D (1991) Temporal evolution of ischemic damage in rat brain measured by proton nuclear magnetic resonance imaging. Stroke 22: 802-808.
Tamai K, Koyama T, Saga T, Morisawa N, Fujimoto K, Mikami Y, Togashi K (2008) The utility of diffusion-weighted MR imaging for differentiating uterine sarcomas from benign leiomyomas. Eur Radiol 18: 723-730.
Maldjian JA, Listerud J, Moonis G, Siddiqi F (2001) Computing diffusion rates in T2-dark hematomas and areas of low T2 signal. AJNR Am J Neuroradiol 22: 112-118.
Hiwatashi A, Kinoshita T, Moritani T, Wang HZ, Shrier DA, Numaguchi Y, Ekholm SE, Westesson PL (2003) Hypointensity on diffusion-weighted MRI of the brain related to T2 shortening and susceptibility effects. AJR Am J Roentgenol 181: 1705-1709.
Shimada K, Ohashi I, Kasahara I, Watanabe H, Ohta S, Miyasaka N, Itoh E, Shibuya H (2004) Differentiation between completely hyalinized uterine leiomyomas and ordinary leiomyomas: three-phase dynamic magnetic resonance imaging (MRI) vs. diffusionweighted MRI with very small b-factors. J Magn Reson Imaging 20: 97-104.
Leppert PC, Baginski T, Prupas C, Catherino WH, Pletcher S, Segars JH. Comparative ultrastructure of collagen fibrils in uterine leiomyomas and normal myometrium. Fertil Steril 2004; 82 Suppl 3: 1182-1187 [PMID: 15474093].
Kim YS, Kim BG, Rhim H, Bae DS, Lee JW, Kim TJ, Choi CH, Lee YY, Lim HK.. Uterine fibroids: semiquantitative perfusion MR imaging parameters associated with the intraprocedural and immediate postprocedural treatment efficiencies of MR imaging-guided high-intensity focused ultrasound ablation. Radiology. 2014 Nov; 273 (2): 462-71. doi: 0.1148/radiol.14132719. Epub 2014 Jul 1.
Thomassin-Naggara I, Dechoux S, Bonneau C, Morel A, Rouzier R, Carette MF, Daraï E, Bazot M. How to differentiate benign from malignant myometrial tumours using MR imaging. Eur adiol. 2013 Aug; 23 (8): 2306-14. doi: 10.1007/s00330-013-2819-9. Epub 2013 Apr 8.
Oscar Tamburrini, Claudia Smiraglio, Nicoletta Caputo, Nadia Mastroianni, Giuseppe Guarascio, Di Cello Annalisa, Michele Morelli, Fulvio ZulloI. The contribution of Magnetic Resonance Imaging in the differential diagnosis between leiomyoma typical, atypical and uterine sarcomas: Personal experience. International Journal of Diagnostic Imaging, 2016, Vol. 3, No. 2.
Solomon D, Breen N, McNeel T. Cervical cancer screening rates in the United States and the potential impact of implementation of screening guidelines. CA Cancer J Clin 2007; 57: 105-111.
Kilickesmez O, Bayramoglu S, Inci E, Cimilli T, Kayhan A. Quantitative diffusion-weighted magnetic resonance imaging of normal and diseased uterine zones. Acta Radiol 2009; 50: 340-347 [PMID: 19235579 DOI: 10.1080/02841850902735858].
Harry VN, Semple SI, Parkin DE, Gilbert FJ. Use of new imaging techniques to predict tumour response to therapy. Lancet Oncol. 2010; 11 (1): 92-102.
Punwani S. Diffusion weighted imaging of female pelvic cancers: concepts and clinical applications. Eur J Radiol. 2011; 78 (1): 21-9.
Browse journals by subject